BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31050105)

  • 1. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
    Reuter C; Chun N; Pariani M; Hanson-Kahn A
    J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer patients' understandings of genetic variants of uncertain significance in clinical care.
    Amano Y; Raz A; Timmermans S; Shkedi-Rafid S
    J Community Genet; 2022 Aug; 13(4):381-388. PubMed ID: 35616809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.
    Menke C; Nagaraj CB; Dawson B; He H; Tawde S; Wakefield EG
    J Genet Couns; 2021 Dec; 30(6):1559-1569. PubMed ID: 33969574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
    Hermel DJ; McKinnon WC; Wood ME; Greenblatt MS
    Fam Cancer; 2017 Jan; 16(1):159-166. PubMed ID: 27401692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Chang J; Seng S; Yoo J; Equivel P; Lum SS
    Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
    Solomon I; Harrington E; Hooker G; Erby L; Axilbund J; Hampel H; Semotiuk K; Blanco A; Klein WMP; Giardiello F; Leonard L
    J Genet Couns; 2017 Aug; 26(4):866-877. PubMed ID: 28127677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Clin Genet; 2015 Dec; 88(6):523-9. PubMed ID: 25640009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient goals, motivations, and attitudes in a patient-driven variant reclassification study.
    Tsai GJ; Garrett LT; Makhnoon S; Bowen DJ; Burke W; Shirts BH
    J Genet Couns; 2019 Jun; 28(3):558-569. PubMed ID: 31163102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
    Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE
    Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.
    Cragun D; Dean M; Baker D; Kelley M; Hooker G; Weidner A; Hunt P; Pal T
    Curr Oncol; 2024 Jun; 31(6):3361-3378. PubMed ID: 38920739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to the patient with a variant of uncertain significance on genetic testing.
    Newey PJ
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):400-408. PubMed ID: 35996232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels.
    Chang EY; Solomon I; Culver JO; Gorman N; Comeaux JG; Lerman C; Quinn EA; Ekstein T
    J Genet Couns; 2023 Jun; 32(3):706-716. PubMed ID: 36747331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
    Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
    Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.
    Pederson HJ; Gopalakrishnan D; Noss R; Yanda C; Eng C; Grobmyer SR
    J Am Coll Surg; 2018 Apr; 226(4):560-565. PubMed ID: 29360614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes.
    Miller IM; Lewis KL; Lawal TA; Ng D; Johnston JJ; Biesecker BB; Biesecker LG
    Genet Med; 2019 Mar; 21(3):748-752. PubMed ID: 29997389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' reactions and follow-up testing decisions related to Tay-Sachs (HEXA) variants of uncertain significance results.
    Yip T; Grinzaid KA; Bellcross C; Moore RH; Page PZ; Hardy MW
    J Genet Couns; 2019 Aug; 28(4):738-749. PubMed ID: 30843643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer patients' experience of receiving variant of uncertain significance results: An Asian perspective.
    Ishak ND; Shaw T; Li ST; Yuen J; Goh HX; Chua ZY; Suresh P; Que FVF; Zhang Z; Chiang J; Ngeow J
    J Genet Couns; 2023 Oct; ():. PubMed ID: 37864575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.
    Underhill-Blazey M; Blonquist T; Chittenden A; Pozzar R; Nayak M; Lansang K; Hong F; Garber J; Stopfer JE
    J Genet Couns; 2021 Feb; 30(1):268-282. PubMed ID: 32851753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
    Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
    JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of uncertain significance (VUS) in cancer predisposing genes: What are we learning from multigene panels?
    Lucci-Cordisco E; Amenta S; Panfili A; Del Valle J; Capellá G; Pineda M; Genuardi M
    Eur J Med Genet; 2022 Jan; 65(1):104400. PubMed ID: 34813939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.